Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024
AUSTIN, Texas, Dec. 14, 2023 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq:AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that management will be available for partnering and institutional one-on-one meetings in San Francisco, during JP Morgan’s Healthcare Conference Week 2024. Nicole Sandford, President and Chief Executive Officer, in addition to Torsten Hombeck, Ph.D., Chief Financial Officer from the management team will be in attendance at the following corporate access and partnering events:
Related news for (AWH)
- Ascend Wellness Holdings Closes $50 Million Private Placement of Senior Secured Notes
- Breaking News: MoBot’s Latest Update as of 03/24/25 07:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/24/25 05:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/24/25 04:00 AM
- MoBot’s Stock Market Highlights – 03/14/25 07:00 PM